Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
ContributorsElhai, Muriel; Boubaya, Marouane; Distler, Oliver; Smith, Vanessa; Matucci-Cerinic, Marco; Alegre Sancho, Juan José; Truchetet, Marie-Elise; Braun-Moscovici, Yolanda; Iannone, Florenzo; Novikov, Pavel I; Lescoat, Alain; Siegert, Elise; Castellví, Ivan; Airó, Paolo; Vettori, Serena; De Langhe, Ellen; Hachulla, Eric; Erler, Anne; Ananieva, Lidia; Krusche, Martin; López-Longo, F J; Distler, Jörg H W; Hunzelmann, Nicolas; Hoffmann-Vold, Anna-Maria; Riccieri, Valeria; Hsu, Vivien M; Pozzi, Maria R; Ancuta, Codrina; Rosato, Edoardo; Mihai, Carina; Kuwana, Masataka; Saketkoo, Lesley Ann; Chizzolini, Carlo; Hesselstrand, Roger; Ullman, Susanne; Yavuz, Sule; Rednic, Simona; Caimmi, Cristian; Bloch-Queyrat, Coralie; Allanore, Yannick; EUSTAR
Published inAnnals of the Rheumatic Diseases, vol. 78, no. 7, p. 979-987
Publication date2019
Abstract
Keywords
- Lung fibrosis
- Rituximab
- Skin fibrosis
- Systemic sclerosis
Affiliation entities
Citation (ISO format)
ELHAI, Muriel et al. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. In: Annals of the Rheumatic Diseases, 2019, vol. 78, n° 7, p. 979–987. doi: 10.1136/annrheumdis-2018-214816
Main files (1)
Article (Published version)
Identifiers
- PID : unige:132376
- DOI : 10.1136/annrheumdis-2018-214816
- PMID : 30967395
Journal ISSN0003-4967
